Grupo Gallego de Investigación en Oncología de Precisión
ONCOGAL
![Foto de Grupo Gallego de Investigación en Oncología de Precisión](/img/grupo.png)
![Foto de Hospital Universitario de Salamanca](/img/noimage_org.png)
Hospital Universitario de Salamanca
Salamanca, EspañaPublicacións en colaboración con investigadores/as de Hospital Universitario de Salamanca (9)
2022
-
Increased quality of life in patients with breakthrough cancer pain after individualized therapy: the CAVIDIOM study
Future oncology (London, England), Vol. 18, Núm. 35, pp. 3913-3927
2021
-
Implementation of the Quality Oncology Practice Initiative Program in Spain: First Results and Implications
JCO oncology practice, Vol. 17, Núm. 8, pp. e1162-e1169
2018
-
Clinical practice evaluation of opioids induced constipation management in oncologic patients: The EIO-50 project
Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 29, pp. viii612
-
Oncologist’s knowledge and implementation of guidelines for breakthrough cancer pain in Spain: CONOCE study
Clinical and Translational Oncology, Vol. 20, Núm. 5, pp. 613-618
-
The quality oncology practice initiative program: Experience in Spain
Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 29, pp. viii570-viii571
2016
-
SEOM Clinical Guideline update for the prevention of chemotherapy-induced nausea and vomiting (2016)
Clinical and Translational Oncology, Vol. 18, Núm. 12, pp. 1237-1242
-
SIADH-related hyponatremia in hospital day care units: clinical experience and management with tolvaptan
Supportive Care in Cancer, Vol. 24, Núm. 1, pp. 499-507
2014
-
Social value of a quality-adjusted life year (QALY) in Spain: the point of view of oncologists
Clinical and Translational Oncology, Vol. 16, Núm. 10, pp. 914-920
2004
-
Anti-emetic efficacy of oral granisetron in the total control of late-onset emesis induced by cyclophosphamide-containing chemotherapy
Clinical and Translational Oncology, Vol. 6, Núm. 1, pp. 22-29